Neuronetics (STIM) Cash & Equivalents (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.23% |
| Dec 31, 2025 | -78.55% |
| Sep 30, 2025 | 330.32% |
| Jun 30, 2025 | -67.86% |
| Mar 31, 2025 | 1,922.40% |
| Dec 31, 2024 | -95.21% |
| Sep 30, 2024 | -51.06% |
| Jun 30, 2024 | -10.66% |
| Mar 31, 2024 | -20.02% |
| Dec 31, 2023 | 66.48% |
| Sep 30, 2023 | -21.90% |
| Jun 30, 2023 | -17.21% |
| Mar 31, 2023 | -21.18% |
| Dec 31, 2022 | -4.56% |
| Sep 30, 2022 | 3.90% |
| Jun 30, 2022 | -12.21% |
| Mar 31, 2022 | -14.17% |
| Dec 31, 2021 | -5.29% |
| Sep 30, 2021 | -14.15% |
| Jun 30, 2021 | -4.55% |
| Mar 31, 2021 | 147.77% |
| Dec 31, 2020 | -3.47% |
| Sep 30, 2020 | -6.07% |
| Jun 30, 2020 | -15.16% |
| Mar 31, 2020 | -15.93% |
| Dec 31, 2019 | -8.09% |
| Sep 30, 2019 | -8.11% |
| Jun 30, 2019 | -6.76% |
| Mar 31, 2019 | -8.07% |
| Dec 31, 2018 | -2.04% |
| Sep 30, 2018 | 634.05% |